AF
OKUR

Amalgamated Financial’s OnKure Therapeutics OKUR Stock Holding History

Amalgamated Financial’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$4K Buy
+132
New +$7.39K ﹤0.01% 2975

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amalgamated Financial's OKUR Position: Q1 2022 in Review

Amalgamated Financial opened a new position in OnKure Therapeutics (OKUR) in Q1 2022: 132 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #2975 among its holdings.

41 funds tracked by Wall St. Rank hold OKUR as of Q1 2022.

  • Amalgamated Financial held 132 shares of OnKure Therapeutics worth $4K as of Q1 2022.
  • OnKure Therapeutics was a new Amalgamated Financial position in Q1 2022.
  • OnKure Therapeutics made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2975 holding.
  • 41 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.